Polomar Health Services (PMHS) Non Operating Income (2022 - 2026)
Polomar Health Services (PMHS) posted Non Operating Income of -$18019.0 for Q2 2026, up 2.47% on a QoQ basis from -$18475.0 in Q1 2026, and up 57.33% year-over-year from -$11452.9 in Q2 2025.
Powered by 
Analysis
Polomar Health Services (PMHS) Non Operating Income (2022 - 2026) Analysis & Trends
Polomar Health Services has reported Non Operating Income for 5 years, with the latest figure at -$18019.0 in Q2 2026.
- On a quarterly basis, Non Operating Income rose 57.33% year-over-year to -$18019.0 in Q2 2026; TTM through Jun 2026 was -$103659.0, a 17.41% increase from a year earlier, with the FY2025 full-year figure at -$150841.0, down 260.54% from the prior year.
- Non Operating Income was -$18019.0 for Q2 2026 at Polomar Health Services, up from -$18475.0 in the prior quarter.
- The five-year high for Non Operating Income was $252.0 in Q4 2022, with the low at -$109680.0 in Q4 2023.
- Average Non Operating Income over 5 years is -$31334.1, with a median of -$25322.0 recorded in 2024.
- The sharpest annual moves came in 2023 and 2024: Non Operating Income slumped 48781.82% in 2023, then surged 72.94% in 2024.
- Over 5 years, Non Operating Income stood at $252.0 in 2022, then slumped by 43623.81% to -$109680.0 in 2023, then soared by 72.94% to -$29677.0 in 2024, then slumped by 55.67% to -$46198.0 in 2025, then soared by 61.0% to -$18019.0 in 2026.
- The last three Non Operating Income figures came in at -$18019.0 (Q2 2026), -$18475.0 (Q1 2026), and -$46198.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | -224.00 Mn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | - |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | - |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | -58.78 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | -1.19 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 278,000.00 |
| 10 | Polomar Health Services | 5.66 Mn | 5.48 Mn | 935,916.00 | -18,019.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -18,019.00 |
| Mar 31, 2026 | -18,475.00 |
| Dec 31, 2025 | -46,198.00 |
| Sep 30, 2025 | -20,967.00 |
| Jun 30, 2025 | -42,230.00 |
| Mar 31, 2025 | -41,447.00 |
| Dec 31, 2024 | -29,677.00 |
| Sep 30, 2024 | -12,160.00 |
| Dec 31, 2023 | -109,680.00 |
| Sep 30, 2023 | -37,485.00 |
| Dec 31, 2022 | 252.00 |
| Sep 30, 2022 | 77.00 |